Invention Application
- Patent Title: Pyrrolopyrimidines as phosphodiesterase vII inhibitors
- Patent Title (中): 吡咯并嘧啶作为磷酸二酯酶vII抑制剂
-
Application No.: US10500040Application Date: 2002-11-08
-
Publication No.: US20050059686A1Publication Date: 2005-03-17
- Inventor: Hans-Michael Eggenweiler , Michael Wolf
- Applicant: Hans-Michael Eggenweiler , Michael Wolf
- Priority: DE10163991.0 20011224
- International Application: PCT/EP02/12533 WO 20021108
- Main IPC: C12N9/99
- IPC: C12N9/99 ; A61K31/519 ; A61K45/00 ; A61P1/04 ; A61P1/12 ; A61P1/16 ; A61P3/10 ; A61P5/00 ; A61P5/02 ; A61P5/38 ; A61P7/00 ; A61P7/02 ; A61P7/04 ; A61P7/06 ; A61P7/08 ; A61P9/04 ; A61P9/08 ; A61P9/10 ; A61P9/12 ; A61P9/14 ; A61P11/00 ; A61P11/02 ; A61P11/04 ; A61P11/06 ; A61P11/08 ; A61P11/10 ; A61P11/16 ; A61P13/02 ; A61P13/08 ; A61P13/12 ; A61P15/00 ; A61P17/00 ; A61P17/04 ; A61P17/06 ; A61P19/02 ; A61P19/06 ; A61P19/08 ; A61P19/10 ; A61P21/04 ; A61P25/00 ; A61P25/04 ; A61P25/14 ; A61P25/16 ; A61P25/24 ; A61P25/28 ; A61P25/30 ; A61P27/02 ; A61P27/14 ; A61P29/00 ; A61P31/00 ; A61P31/04 ; A61P31/10 ; A61P31/14 ; A61P31/16 ; A61P31/18 ; A61P31/20 ; A61P31/22 ; A61P33/06 ; A61P35/00 ; A61P35/02 ; A61P35/04 ; A61P37/00 ; A61P37/06 ; A61P37/08 ; A61P41/00 ; A61P43/00 ; C07D487/04 ; C07D487/02
Abstract:
Pyrrolopyrimidine derivatives of the formula I in which R3, R4, R5, R6 and X are as defined in claim 1, act as phosphodiesterase VII inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS.
Public/Granted literature
- US07498334B2 Pyrrolopyrimidines as phosphodiesterase VII inhibitors Public/Granted day:2009-03-03
Information query
